The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.34BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Trailing P/E
13.89x
vs Medical Care Facilities peers
Updated Oct 28, 2026
Revenue (TTM)
1.95BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Profit Margin
8.96%
vs Medical Care Facilities peers
Updated Oct 28, 2026
Beta
0.6100x
vs all stocks
Updated Oct 28, 2026
52-Week Change
61.66%
vs all stocks
Updated Oct 28, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 28, 2026
Market Capitalization
2.34BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Enterprise Value
2.54BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Trailing P/E
13.89x
vs Medical Care Facilities peers
Updated Oct 28, 2026
Forward P/E
11.90x
vs Medical Care Facilities peers
Updated Oct 28, 2026
PEG Ratio
1.31x
vs Medical Care Facilities peers
Updated Oct 28, 2026
Price to Sales (TTM)
1.21x
vs Medical Care Facilities peers
Updated Oct 28, 2026
Price to Book (MRQ)
2.61x
vs Medical Care Facilities peers
Updated Oct 28, 2026
Enterprise to Revenue
1.30x
vs Medical Care Facilities peers
Updated Oct 28, 2026
Enterprise to EBITDA
9.63x
vs Medical Care Facilities peers
Updated Oct 28, 2026
Gross Margin
27.16%
vs Medical Care Facilities peers
Updated Oct 28, 2026
Profit Margin
8.96%
vs Medical Care Facilities peers
Updated Oct 28, 2026
Operating Margin
13.41%
vs Medical Care Facilities peers
Updated Oct 28, 2026
Return on Assets (TTM)
7.11%
vs Medical Care Facilities peers
Updated Oct 28, 2026
Return on Equity (TTM)
20.39%
vs Medical Care Facilities peers
Updated Oct 28, 2026
Revenue (TTM)
1.95BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Revenue per Share (TTM)
23.87USDUpdated Oct 28, 2026
Quarterly Revenue Growth
4.00%
vs Medical Care Facilities peers
Updated Oct 28, 2026
Gross Profit (TTM)
511.77MUSD
vs all stocks (USD)
Updated Oct 28, 2026
EBITDA (TTM)
267.85MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Net Income (TTM)
174.81MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Quarterly Earnings Growth (YoY)
1.50%
vs Medical Care Facilities peers
Updated Oct 28, 2026
Operating Cash Flow (TTM)
246.86MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Levered Free Cash Flow (TTM)
160.78MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 28, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Oct 28, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 28, 2026
Payout Ratio
0.00%
vs Medical Care Facilities peers
Updated Oct 28, 2026
Revenue
1.91BUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
1.42BUSDFY2025 · Dec 31, 2025
Gross Profit
493.70MUSDFY2025 · Dec 31, 2025
Operating Income
231.09MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
216.43MUSDFY2025 · Dec 31, 2025
Income Tax Expense
51.04MUSDFY2025 · Dec 31, 2025
Net Income
165.39MUSDFY2025 · Dec 31, 2025
EBIT
252.40MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
256.55MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
240.79MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
35.97MUSDFY2025 · Dec 31, 2025
EPS (Basic)
1.99USDFY2025 · Dec 31, 2025
EPS (Diluted)
1.94USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
82.98MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
82.98MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
165.39MUSDFY2025 · Dec 31, 2025
Operating Cash Flow
270.23MUSDFY2025 · Dec 31, 2025
Free Cash Flow
251.78MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
375.24MUSDFY2025 · Dec 31, 2025
Interest Paid
34.38MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
165.39MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
21.83MUSDFY2025 · Dec 31, 2025
Deferred Taxes (CF)
52.19MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
18.05MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
-3.63MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
30.56MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-14.14MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-18.46MUSDFY2025 · Dec 31, 2025
Net Acquisitions
6.80MUSDFY2025 · Dec 31, 2025
Purchase of Investments
-29.85MUSDFY2025 · Dec 31, 2025
Sale of Investments
26.67MUSDFY2025 · Dec 31, 2025
Other Investing Activity
-3.46MUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-18.30MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025
Long-term Debt Payments
-20.75MUSDFY2025 · Dec 31, 2025
Common Stock Repurchase
-86.68MUSDFY2025 · Dec 31, 2025
Other Financing Charges
-3.25MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
-107.49MUSDFY2025 · Dec 31, 2025
Shares Outstanding
81.22MSharesUpdated Oct 28, 2026
Float Shares
77.99MSharesUpdated Oct 28, 2026
Shares Short
4.61MSharesUpdated Oct 28, 2026
Short Ratio
6.37days
vs all stocks
Updated Oct 28, 2026
Short % of Shares Outstanding
8.09%
vs all stocks
Provider-reported. Shares Short ÷ Shares Outstanding on this page gives 5.68%.Updated Oct 28, 2026
% Held by Insiders
2.03%
vs all stocks
Updated Oct 28, 2026
% Held by Institutions
106.98%
vs all stocks
Updated Oct 28, 2026
Total Cash (MRQ)
404.20MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Total Cash per Share (MRQ)
5.10USDUpdated Oct 28, 2026
Total Debt (MRQ)
619.96MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Total Debt to Equity (MRQ)
0.7037x
vs Medical Care Facilities peers
Updated Oct 28, 2026
Current Ratio (MRQ)
1.32x
vs Medical Care Facilities peers
Updated Oct 28, 2026
Book Value per Share (MRQ)
11.11USDUpdated Oct 28, 2026
Total Assets
2.25BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
763.51MUSDFY2025 · Dec 31, 2025
Total Liabilities
1.38BUSDFY2025 · Dec 31, 2025
Total Non-current Assets
1.48BUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
921.93MUSDFY2025 · Dec 31, 2025
Total Current Liabilities
458.91MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
375.24MUSDFY2025 · Dec 31, 2025
Other Short-term Investments
124.48MUSDFY2025 · Dec 31, 2025
Accounts Receivable
229.66MUSDFY2025 · Dec 31, 2025
Accounts Payable
37.22MUSDFY2025 · Dec 31, 2025
Short-term Debt
38.40MUSDFY2025 · Dec 31, 2025
Long-term Debt
596.22MUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
268.69MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
830.00KUSDFY2025 · Dec 31, 2025
Retained Earnings
-83.15MUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
865.85MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
16.90USDUpdated Oct 28, 2026
52-Week High
30.05USDUpdated Oct 28, 2026
52-Week Change
61.66%
vs all stocks
Updated Oct 28, 2026
Beta
0.6100x
vs all stocks
Updated Oct 28, 2026
50-Day MA
26.66USDUpdated Oct 28, 2026
200-Day MA
23.70USDUpdated Oct 28, 2026
Avg 10-Day Volume
658.54KSharesUpdated Oct 28, 2026
Avg 30-Day Volume
730.81KSharesUpdated Oct 28, 2026
Diluted EPS (TTM)
2.09USDUpdated Oct 28, 2026
Other Income / Expense
21.31MUSDFY2025 · Dec 31, 2025
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.35: grey zoneSignificant
Altman Z-Score: 2.35
Supply Chain
Downstream position: depends on 12 industries, supplies 7Notable
Outgoing: 7.00Incoming: 12.00
High connectivity hub: 19 industry connectionsNotable
Total Connections: 19.00
Scale
Market cap is $2.34B, above the global median of $1.14BNotable
Market cap (USD): 2,343,344,335Global Median: 1,137,180,293.291
Revenue is $1.95B, above the global median of $566.17MNotable